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Abstract 28 
 NF-kappaB (NF-κB) signaling is involved in regulating a great number of normal 29 
and abnormal cellular events. However, little is known about its role in ovarian 30 
follicular development. In this study, we found NF-κB signaling is activated during 31 
the transition from secondary to antral follicles. We generated active NF-κB mice and 32 
found that antral follicular numbers were higher than wild-types ovaries. Activation of 33 
NF-κB signaling could enhance granulosa cell proliferation and regress granulosa cell 34 
apoptosis of mouse ovarian follicles. Higher FSHR and LHCGR expressions were 35 
observed in active NF-κB ovaries compared to wild-type. Furthermore, we confirmed 36 
that NF-κB signaling was indeed involved in the granulosa cell viability and 37 
proliferation through FSHR using COV434 cell line. This is the first experimental 38 
evidence that NF-κB signaling is implicated in the control of follicular development 39 
through FSHR and its corresponding target molecules, which might be achieved by 40 
targeting proliferation and apoptosis in follicular granulosa cells.  41 
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Introduction 58 
The ovarian follicles are the fundamental functional unit of the ovary, and they 59 
are morphologically composed of an oocyte surrounded by granulosa and theca cells, 60 
which protect and support the development of the oocytes. Ovarian follicle maturation 61 
proceeds through primordial, primary, secondary and mature antral follicular stages. 62 
At birth, the ovary contains approximately one million hibernating primordial follicles 63 
and some of them become activated to go through folliculogenesis during puberty. 64 
The various developmental stages that the activated primordial follicles pass through 65 
subsequent to follicular development during folliculogenesis are also shared by many 66 
animal species. The numbers of primary follicles, which derive from a large number  67 
of primordial follicles, decreases when they develop to secondary and antral follicles 68 
under the appropriate hormonal environment. Most follicles normally degenerate to 69 
atretic follicles, and this can occur at all stages of follicular development (McGee & 70 
Hsueh, 2000).  71 
Ovarian follicle development is precisely regulated by a sequence of autocrine 72 
and paracrine factors. Additionally, it relies on the input from endocrine hormones 73 
including pituitary and ovarian hormones. The balance of these hormones is 74 
especially vital since it determines whether a developing follicle becomes maturated 75 
or undergoes atresia (Bertoldo, Bernard, Duffard, Mermillod, & Locatelli, 2013; 76 
Matsuda, Inoue, Manabe, & Ohkura, 2012; Raju et al., 2013). Amongst these 77 
hormones, follicle-stimulating hormone (FSH) is undoubtedly the most important, 78 
because it plays a role in both the survival of early antral-staged follicles and the 79 
growth, activation and differentiation of prenatal follicles (Fauser, 1994; Hsueh, 80 
McGee, Hayashi, & Hsu, 2000). FSH-dominated the exponential growth of ovarian 81 
follicles acts principally as a consequence of the proliferation of granulosa cells. 82 
Beyond that, activin also plays a very important role on regulating the proliferation 83 
and differentiation of granulosa cells, but it is indispensable for the removal of 84 
FOXO1-dependent repression and positive signaling by Smad2/3 (Park et al., 2005). 85 
Accumulating evidence indicates that the death of follicular granulosa cells is partly 86 
responsible for causing follicular atresia (Liu, Yue, Ma, Sun, & Tan, 2003; Murdoch, 87 
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1995). Interfering with steroidogenesis and the dexamethasone exposure could lead to 88 
apoptosis of granulosa cells, which in turn triggers follicular atresia. In contrast, 89 
insulin-like growth factor (IGF) could restrict follicular atresia through preventing 90 
apoptosis in granulosa cells as induced by dexamethasone (deMoura, Chamoun, 91 
Resnick, & Adashi, 2000).The cellular and molecular mechanisms underlying the 92 
developmental fate of ovarian follicles is not entirely understood (Yu et al., 2004), 93 
therefore, more elaborative studies on regulating follicular development are necessary 94 
to elucidate the underlying molecular biological mechanisms in response to FSH and 95 
activin.  96 
Nuclear factor-κB (NF-κB) was identified as a regulator of expression of the κB 97 
light chain in B cells thirty years ago (Hayden & Ghosh, 2008; Sen & Baltimore, 98 
1986). But, NF-κB has being intensively studied since a variety of internal and 99 
external stimuli could activate the transcription factors, which also regulate numerous 100 
crucial gene expressions in a multiple organisms during physiological and 101 
pathological events. For a long time, it has been considered that the NF-κB is the only 102 
immunologically relevant signaling pathway since it has been found to play an 103 
important and indispensable role on regulating the expression of inducers and 104 
effectors in the unreserved networks that define responses to pathogens (Razani, 105 
Reichardt, & Cheng, 2011). However, the biological forces of NF-κB signaling reach 106 
extensively to transcriptional regulation beyond the boundaries of the immune 107 
response, acting widely to impact on gene expression events that are involved in cell 108 
survival, differentiation and proliferation. NF-κB family of transcription factors is 109 
composed of five members including p50, p52, p65 (RelA), c-Rel, and RelB. 110 
Activation of NF-κB proceeds through the liberation of NF-κB dimers from inactive 111 
state, in which NF-κB dimers are associated with one of three IκB proteins. The 112 
released NF-κB undergoes thetranslocation to nucleus, where the transcription of 113 
target genes is promoted via its binding to specific DNA sequences. A variety of 114 
stimuli including both endogenous and exogenous stresses could activate NF-κB 115 
signaling (Chen & Greene, 2004). Meanwhile, the correlations between NF-κB 116 
signaling and other physiological signaling pathways are still obscure although new 117 
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studies continue to provide more evidence (Adler et al., 2007).More interestingly, 118 
despite it has been known that ovarian follicular atresia is coupled with granulosa cell 119 
apoptosis, the regulators initiating granulosa cell apoptosis have not been fully 120 
addressed. There was a report that NF-κB signaling was deemed to be one of vital 121 
genes controlling granulosa cell apoptosis (Valdez & Turzillo, 2005). But, more 122 
precise experimental evidence is certainly required to reveal the interplaying and 123 
underlying mechanism. In this study, we investigated whether NF-κB signaling was 124 
involved in regulating follicular development and atresia through its effect on 125 
granulosa cell survival using activated NF-κB transgenic mice. We systematically 126 
examined the development of the ovarian follicles in activated NF-κB transgenic mice 127 
and especially focused on the correlation between antral follicular development and 128 
granulosa cell growth and death.  129 
 130 
 131 
Materials and Methods 132 
Mice  133 
Knockin (NF-κB1C59S) mice were obtained from Modern Animal Research Center of 134 
Nanjing University. Exon 6 of the mouse NF-κB1（p50）gene, codon TGT for Cys-59 135 
was mutated to TCA encoding Ser by means of site-directed mutagenesis. p50 with 136 
this substitution retained a maximum DNA-binding activity (Mitomo et al., 1994; 137 
Toledano, Ghosh, Trinh, & Leonard, 1993). This means that the NF-κB signal is 138 
activated to some extent. A PGK-neo cassette was inserted in an intron near the 139 
mutation point as a selective marker. Standard cloning techniques were used to 140 
construct targeting vectors. The fragment containing the 5kb 5' arm, mutation point, 141 
PGK-neo and 5kb 3'arm. The targeting vector was linearized and transferred to the 142 
C57BL/6NTac derived ES cell line. The target clone was screened by Long Range 143 
PCR and Southern blot. ES cell clones carrying the expected NF-κB1(p50）mutation 144 
were injected into E3.5 C57BL/6 blastocysts that were subsequently transferred into 145 
foster mothers. Knockin mutation was confirmed by sequencing tail DNA samples 146 
from offspring mice. Multiplex PCR genotyping used four primers to detect the 147 
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knockin alleles (primer 1, primer 2, primer 3, and primer 4). The following conditions 148 
of PCR reaction are used to detect Wild type and NF-κB1C59S alleles: 94 °C, 5min; 41 149 
cycles of 94 °C, 30 s; 58 °C, 30 s; 72 °C, 45 s; 72 °C, 5 min. Primers were obtained 150 
from Sangon Biotech, China, and the sequences are listed in Supplementary Figure 1. 151 
All of the offspring mice were maintained under a 12 light/12 dark cycle at a constant 152 
temperature of approximately 25°C and humidity between 35-75%. This study was 153 
carried out in strict accordance with the recommendations of the Guide for the Care 154 
and Use of Laboratory Animals of the National Institutes of Health. The protocol was 155 
approved by the Committee on the Ethics of Animal Experiments of the 156 
JinanUniversity. All surgery was performed under pentobarbital anesthesia, and all 157 
efforts were made to minimize mouse suffering. 158 
 159 
Histology 160 
Briefly, ovaries from 25-week-old wild-type (C57) or NF-κ B1C59Smice were 161 
fixed in 4% paraformaldehyde at 4 °C for 24 hours. The specimens were then 162 
dehydrated, cleared in xylene, and embedded in paraffin wax. The embedded 163 
specimens were sectioned serially at 5 μm using a rotary microtome (Leica, Germany). 164 
The sections were either stained with hematoxylin and eosin (HE), periodic acid 165 
Schiff (PAS) reaction or Masson’s trichrome dyes (Li et al., 2014). The PAS and 166 
Masson staining were used to reveal the presence of atretic follicle in the ovarian 167 
sections. The stained histological sections were photographed using an 168 
epifluorescence microscope and an attached camera (Olympus IX51, Leica DM 169 
4000B) at 200× magnification. 170 
 171 
Classification of developing follicles in ovarian sections 172 
The follicles in the ovarian histological sections were developmentally staged 173 
according to their morphology as: primary, secondary, antral or atretic follicles. 174 
Briefly, Oocyte surrounded by a single or several layer/s of cuboidal granulosa cells 175 
were classified as a primary or secondary follicle, respectively. When an antrum was 176 
present, it was described as an antral follicle. The presence of zona pellucida remnants 177 
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was classified as an end-stage atretic follicle (Myers, Britt, Wreford, Ebling, & Kerr, 178 
2004). Every 5th and 6th histological sections were selected for comparison and 179 
evaluation. Follicles were only counted if appeared in one histological section but not 180 
in the others (Myers, Britt, Wreford, Ebling, & Kerr, 2004). 181 
 182 
Immunohistological Staining 183 
Sections of mouse ovary were dewaxed, hydrated, incubated in citrate buffer (pH 184 
6.0) and then heated in a microwave for antigen retrieval. Immunofluorescent staining 185 
was conducted on these treated sections using various antibodies. Briefly, the sections 186 
were incubated in the following primary antibodies diluted using PBT-NGS: IκBα 187 
(1:200, catalog#4814, Cell Signaling Technology, USA), p65 (1:200, catalog#6956, 188 
Cell Signaling Technology, USA), FSHR (1:100, catalog#22665-1-AP, Proteintech, 189 
China), LHCGR (1:100, catalog#BA3590, Boster, China), Ki67 (1:200, catalog 190 
BS1454, Bioworld, USA), Proliferating Cell Nuclear Antigen (PCNA) (1:200, catalog 191 
ab29, Abcam, USA), Fas (1:200, catalog#8023, Cell Signaling Technology, USA), 192 
FasL (1:100, catalog#PB0042, Boster, China), C-Caspase-3 (1:200, catalog#9664, 193 
Cell Signaling Technology, USA), α-SMA (1:400, catalog#ab5694, Abcam, USA) at 194 
4 °C overnight. Following three 5 min washes in PBS, the sections were further 195 
incubated with goat anti-rabbit IgG or goat anti-mouse IgG conjugated Alexa Fluor 196 
555 or 488 (1:1000, Life Technologies, USA) for 1 hour. The sections were 197 
counterstained with DAPI (1:1000, Life Technologies, USA) at room temperature for 198 
30 min before examination. Photographs were taken of the stained histological 199 
sections using an epifluorescence microscope (Olympus IX51, Leica DM 4000B) at 200 
200× magnification. 201 
 202 
RNA isolation and quantitative PCR 203 
Total RNA was isolated from 25-week-old mouse ovary or COV434 cells using a 204 
Trizol kit (Invitrogen, USA) according to the manufacturer’s instructions. First-strand 205 
cDNA was synthesized to a final volume of 20 μl using iScriptTM cDNA Synthesis 206 
Kit (BIO-RAD, USA). Following reverse transcription, PCR amplification of the 207 
  8 
cDNA was performed as described previously (Dugaiczyk et al., 1983; Maroto et al., 208 
1997). SYBR® Green qPCR assays were then performed using a PrimeScriptTM RT 209 
reagent kit (Takara, Japan). All specific primers used are described in Supplementary 210 
Fig. 2. PCR reactions were performed in a Bio-Rad S1000TM Thermal cycler 211 
(Bio-Rad, USA) and ABI 7000 thermal cyclers, respectively. The housekeeping gene 212 
GAPDH was run in parallel to confirm that equal amounts of RNA used in each 213 
reaction. The expression of the genes was normalized to GAPDH, and the expression 214 
level was compared by ΔΔCt. The q-PCR result was representative of three 215 
independent experiments. 216 
 217 
Western blot  218 
25-week-old mouse ovary or COV434 cells was collected and lysed with 219 
CytoBuster™ Protein Extraction Reagent (#71009, Novagen). The total protein 220 
concentration was determined usinga BCA quantification kit (BCA01, 221 
DingGuoBioTECH, China). Samples containing equal amounts of protein were 222 
resolved by SDS-PAGE and then transferred to PVDF membranes (Bio-Rad, USA). 223 
The membranes were blocked with 5% Difco™ skimmed milk (BD) and then 224 
incubated with primary and secondary antibodies. The antibodies used were IκBα 225 
(1:1000, catalog#4814, Cell Signaling Technology, USA); p65 (1:1000, catalog#6956, 226 
Cell Signaling Technology, USA); FSHR (1:500, catalog#22665-1-AP, Proteintech, 227 
China); PCNA (1:1000, catalog ab29, Abcam, USA); Fas (1:1000, catalog#8023, Cell 228 
Signaling Technology, USA); C-Caspase3 (1:1000, catalog#9664, Cell Signaling 229 
Technology, USA); Phospho-AKT1 (Thr308) (1:1000, catalog#SB240133, Thermo 230 
Fisher scientific, USA); β-actin (1:2000, Proteintech, China); HRP-conjugated 231 
anti-mouse IgG and anti-rabbit IgG (1:3000, Cell Signaling Technology, USA). All 232 
primary and secondary antibodies used were diluted to 1:1000 and 1:2000 in 5% 233 
skimmed milk or BSA, respectively. The protein bands of interest were visualized 234 
using an ECL kit (#34079, Thermo Fisher Scientific Inc, USA) and GeneGnome5 235 
(Syngene, UK). The staining intensity of the bands was determined and analyzed 236 
using Quantity One software (Bio-Rad, USA).  237 
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 238 
Cell lines and culture 239 
COV434 (human ovarian granulosa cells) was obtained from GuangZhouJennio 240 
Biotech Co., Ltd, China. The cells were cultured in RPMI Medium 1640 basic (1X) 241 
(Gibco) supplemented with 10% fetal bovine serum (Gaithersburg, MD, USA) in a 242 
humidified incubator with 5% CO2 at 37 °C.  243 
 244 
CCK8 Assays and Hoechst/PI staining 245 
    COV434 cells, divided into Control, LPS (1μg/mL, 5μg/mL, 10μg/mL,Sigma, 246 
USA), Bay 11-7082 (5μM, 10μM,calbiochem, Germany), were seeded into 96-well 247 
plates. These cells (1 × 105 cells/mL) were maintained in RPMI Medium 1640 basic 248 
(1×) + 10% fetal bovine serum at 37 °C and 5% CO2. The cell viability was assessed 249 
using CCK8 assay (cholecystokinin-8). Briefly, 10 μl of CCK8 reagent (Dojindo, 250 
Kumamoto, Japan) was added to the 96-well plates and incubated for 12h, 24h and 251 
48h at 37 °C. The absorbance values were measured at 450 nm using a Bio-Rad 252 
model 450 microplate reader (Bio-Rad, USA). The cell viability was indirectly 253 
determined by examining the ratio of the absorbance value of LPS-treated cells, and 254 
Bay 11-7082-treated cells relative to the control cells.For Hoechst (1:1000, Sigma, 255 
USA) / Propidium Iodide (PI, 1:1000, Sigma, USA) staining, the cells were cultured 256 
and washed twice with cold PBS, and then incubated with Hoechst/PI for 45 min at 257 
37°C in the dark. 258 
 259 
Image acquisition and analysis 260 
Whole ovaries were photographed using a fluorescence stereomicroscope 261 
(Olympus MVX10) and analyzed imaging software (Image-Pro Plus 6.0). The stained 262 
sections of ovaries were photographed using an epi-fluorescent microscope (Olympus 263 
IX51, Leica DM 4000B) at 200x and 400x magnification and analyzed with Olympus 264 
software (Leica CW4000 FISH). 265 
For quantification of proliferation, apoptosis and differentiation, the number of 266 
IκBα+, p65+, FSHR+, LHCGR+, Ki67+, PCNA+, FasL+, Fas+, cleaved-Caspase-3+ 267 
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granulosa cells versus total DAPI+ granulosa cells were counted for each follicle or 268 
visual field. The results were then compared between each group with the follicles 269 
only at the same developmental stage. For immunofluorescent staining of 270 
25-week-old ovaries, total positive granulosa cells in secondary follicles or antral 271 
follicles were counted (Chen et al., 2015). Six ovaries of each experimental group 272 
were used. 273 
 274 
Data Analysis 275 
Data analyses and construction of statistical charts were performed using 276 
GraphPad Prism 5 software (GraphPad Software, La Jolla, USA). The results were 277 
presented as the mean value (x̅ ± SEM). Statistical analysis was performed using IBM 278 
SPSS Statistics 19.0 software. Statistical significance was determined using an 279 
independent samples t test, and non-parametric independent samples Kruskal-Wallis 280 
test. P < 0.05 was considered to be statistically significant. 281 
 282 
 283 
Results 284 
The dynamic change of NF-κB signaling pathway is associated with the transition 285 
from mouse ovarian secondary to antral follicles. 286 
Immunofluorescent staining against IκBα (red, Fig. 1A-D1), p65 (green, Fig. 287 
1E-H1) and p50 (brown, Fig. 1I-L) was implemented on transverse sections of 288 
25-week-old C57 mouse ovaries to determine the expression pattern of NF-κB 289 
signaling pathway in developing ovarian follicles. The results demonstrated that IκBα , 290 
p65 and p50 are expressed in granulosa cells (Fig. 1). IκBα expression was increased 291 
from primordial follicles to secondary follicles, but reduced at antral follicles (Fig. 292 
1A-D1), while p65 and p50 expression consistently increased until the follicles 293 
developed to antral follicles (Fig. 1E-L), which is schematically illustrated by the 294 
sketch in Fig. 1M. This indicates that NF-κB signaling is activated during the 295 
transition from secondary to antral follicles since IκBα is degraded, while p65 and 296 
p50 up-regulated (Razani, Reichardt, & Cheng, 2011).  297 
  11 
To address the role of NF-κB signaling on the follicular transition, we generated 298 
active NF-κB mice through mutating serine into cysteine at the nos. 59 of sixth exon 299 
(Mitomo et al., 1994; Toledano, Ghosh, Trinh, & Leonard, 1993) (Fig. 2A). p50 300 
immunofluorescent staining and western blot data showed that higher expression of 301 
p50 in active NF-κB ovaries than the one in wild-type (Supplementary Fig. 3; WT = 302 
44.23 ± 3.110%, N=4; NF-κB1C59S =74.85 ± 2.833%, N=4;Supplementary Fig. 3E; 303 
WT = 0.1730 ± 0.01159, N=3; NF-κB1C59S =0.2857 ± 0.03122, N=3;Supplementary 304 
Fig. 3G). There was no obvious difference in appearance, ovary weight and surface 305 
area between the wild-type and active NF-κB mouse ovaries, although it appears that 306 
there were more blood vessels on the ovary surface of active NF-κB mice than the one 307 
on the wild-type (Fig. 2B;WT = 5.450±0.3114mg, N=10; NF-κB1C59S =5.722 ± 308 
0.2373mg, N=9;Fig. 2B1 ; WT = 3.660 ± 0.1288mm2, N=5; NF-κB1C59S= 3.904 309 
±0.09469mm2, N=5; Fig. 2B2). To assess the angiogenesis in ovary, we implemented 310 
immunofluorescent staining against ɑ-SMA (ɑ-smooth muscle actin), the marker for 311 
vascular smooth muscle(Badid et al., 2002), on the ovary section, but we did not find 312 
the change of ɑ-SMA expression between wild-type and active NF-κB ovaries 313 
(Supplementary Fig. 4; WT = 103.7 ± 5.333, N=6; NF-κB1C59S = 116.7 ± 5.649, N=6; 314 
Supplementary Fig. 4G). Quantitative PCR data demonstrated the lower expression of 315 
IκBα and higher expression of p65 in active NF-κB ovaries than the one in wild-type 316 
(WT = 1.000 ± 0.02608, N=3; NF-κB1C59S =0.5419 ± 0.05249, N=3; Fig. 2C; WT = 317 
1.000 ± 0.1094, N=3; NF-κB1C59S = 4.385 ± 0.4715, N=3; Fig. 2D). IκBα 318 
immunofluorescent staining showed that IκBα expression on granulosa cells 319 
(indicated by arrows) of the secondary and antral folliculeson ovary sections was also 320 
reduced in active NF-κB ovaries relative to wild-type (Fig. 2E), and the ratios of IκBα 321 
positive granulosa cell numbers in secondary and antral follicles of active NF-κB 322 
mice were significantly lower than the ones in wild-type mice (secondary: WT = 323 
28.67 ± 2.404%, N=6; NF-κB1C59S =10.42 ± 1.052%, N=6; Fig. 2E1; antral: WT = 324 
6.450 ± 0.7325%, N=6; NF-κB1C59S = 2.967 ± 0.4271%, N=6; Fig. 2E2). Furthermore, 325 
p65 immunofluorescent staining on ovary section demonstrated more p65 expression 326 
in cell nuclei of active NF-κB ovary follicles (indicated by arrows) than in wild-type 327 
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ovary follicles (Fig. 2F), and the ratio of p65-labelled NF-κB nuclear translocation in 328 
active NF-κB ovary follicles dramatically increased (WT = 42.38 ± 1.493%, N=6; 329 
NF-κB1C59S = 65.92 ± 1.945%, N=6; Fig. 2F1). Meanwhile, western blot data 330 
manifested the similar results with the one from immunofluorescent staining. IκBα 331 
expression at the protein level decreased significantly in active NF-κB ovaries relative 332 
to wild-type (Fig. 2G; WT = 1.448 ± 0.1560, N=3; NF-κB1C59S =0.9547 ± 0.04836, 333 
N=3; Fig. 2G1). All of those data imply that the mouse model of NF-κB signaling 334 
activation in the ovary follicles is well established.  335 
 336 
Activation of NF-κB signaling raised the numbers of mouse ovarian antral follicles. 337 
To assess the effect of elevated NF-κB signaling on follicular development, the 338 
numbers of differently developing ovarian follicles on the HE stained vertical sections 339 
of ovaries were counted (Fig. 3A), and the results showed that there was little change 340 
in the numbers of primary follicles, secondary follicles and corpus luteum except for 341 
the significant increase of antral follicle numbers between wild-type and active 342 
NF-κB mice (primary: WT = 2.500 ±0.4773, N=10; NF-κB1C59S = 1.867 ± 0.3763, 343 
N=15; secondary: WT = 3.071 ± 0.6501, N=14; NF-κB1C59S = 2.938 ± 0.3223, N=16; 344 
antral: WT = 7.000 ± 0.2572, N=17; NF-κB1C59S = 9.923 ± 0.4995, N=13; corpus 345 
luteum: WT = 2.357 ± 0.1693, N=14; NF-κB1C59S = 2.200 ± 0.4047, N=15; Fig. 3B). 346 
The folliculogenesis from primary follicles has been clearly associated with the 347 
regulation of endocrine signals, especially the estrogen converted from androgen, in 348 
which cytochrome P450 family (CYP) plays an important role (Fan et al., 2008). Here, 349 
quantitative PCR data showed that CYP11a1 and CYP19a1 expressions were 350 
up-regulated, while CYP17a1 expression remained unchanged in active NF-κB mice 351 
in comparison to wild-type mice (WT =1.000 ± 0.06945, N=3; NF-κB1C59S = 1.586 352 
±0.1879, N=3; Fig. 3C; WT =1.000 ± 0.04619, N=3; NF-κB1C59S = 0.9611 ±0.02268, 353 
N=3; Fig. 3D; WT =1.000 ± 0.08749, N=3;NF-κB1C59S = 3.309 ± 0.2245, N=3; Fig. 354 
3E). These data suggest that activation of NF-κB signaling promote the generation of 355 
antral follicles, and the subsequent high expression of CYP11a1 and CYP19a1 may 356 
contribute to the formation of estrogen.  357 
  13 
Due to the obvious importance of gonadotropin on stimulating the ovarian 358 
development, the expressions of FSHR (Follicle Stimulating Hormone Receptor) and 359 
LHCGR (Luteinizing Hormone/Choriogonadotropin Receptor) were determined in 360 
the antral follicles of wild-type and active NF-κB mice using immunofluorescent 361 
staining. Immunofluorescent staining showed that both FSHR and LHCGR 362 
expressions in granulosa cells of active NF-κB mouse antral follicles were higher than 363 
the one in wild-type mice (Fig. 4A-B). This phenotype was confirmed by the 364 
quantitative PCR data (FSHR: WT = 1.000 ± 0.1424, N=3; NF-κB1C59S = 2.659 ± 365 
0.4128, N=3; LHCGR: WT = 1.000 ± 0.1017, N=3;NF-κB1C59S = 3.331 ± 0.2323, 366 
N=3; Fig. 4C). Moreover, western blot data manifested that FSHR expression in 367 
active NF-κB mouse ovaries significantly up-regulated in comparison to wild-type at 368 
protein level (Fig. 4D; WT = 0.3120 ± 0.07679, N=3; NF-κB1C59S = 0.6357 ± 0.02774, 369 
N=3; Fig. 4D1). This indicates that the activation of NF-κB signaling could promote 370 
the expressions of gonadotropin receptors in ovarian granulosa cells.  371 
 372 
Activation of NF-κB signaling enhanced granulosa cell proliferation of mouse 373 
ovarian secondary and antral follicles. 374 
Immunofluorescent staining against Ki67 and PCNA was implemented on the 375 
mouse transverse sections to assess the effects of NF-κB signaling on cell 376 
proliferation of the ovarian secondary and antral follicles (Fig. 5A). The results 377 
showed significantly higher expressions of both Ki67 (Secondary: WT = 28.60 ± 378 
1.770%, N=6; NF-κB1C59S = 40.83± 1.883%, N=6; Antral: WT = 30.08 ± 2.538%, 379 
N=6; NF-κB1C59S = 46.50 ± 3.610%, N=6; Fig. 5A1) and PCNA (Secondary: WT = 380 
48.22± 2.411%, N=6; NF-κB1C59S = 51.08 ± 2.951%, N=6; Antral: WT = 41.33± 381 
2.472%, N=6; NF-κB1C59S = 56.75 ± 3.25%, N=6; Fig. 5A2) in the granulosa cells of 382 
NF-κB signaling-activated mouse secondary and antral follicles compared to 383 
wide-type. Furthermore, western blot data also demonstrated that there was a 384 
significantly increase of PCNA expression in NF-κB signaling-activated mouse 385 
ovaries compared to wild-type (Fig. 5B; WT = 0.4703 ± 0.02206, N=3; NF-κB1C59S = 386 
0.6063 ±0.02571, N=3; Fig. 5B1). Meanwhile, the expressions of bone morphogenetic 387 
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protein 15 (Bmp15) and growth differentiation factor 9 (Gdf9), both oocyte-secreted 388 
factors that are involved in regulation of the granulosa cell proliferation during 389 
follicular development (Reader et al., 2011), were determined in NF-κB 390 
signaling-activated and wild-type mouse ovaries using quantitative PCR. The results 391 
showed that activation of NF-κB signaling caused the enhanced expressions of both 392 
Bmp15 and Gdf9 in comparison to wild-type mice (Bmp15: WT = 1.000 ± 0.09598, 393 
N=3; NF-κB1C59S = 2.024 ±0.2289, N=3; Gdf9: WT = 1.000 ± 0.1106, N=3; 394 
NF-κB1C59S = 2.285 ± 0.1832, N=3; Fig. 5C). All of those data indicated that the 395 
accelerated process of conversion from secondary to antral follicles might partially 396 
due to promoted granulosa cell proliferation under the activation of NF-κB signaling.  397 
 398 
Activation of NF-κB signaling regressed granulosa cell apoptosis of mouse ovarian 399 
secondary and antral follicles. 400 
 PAS and Masson staining were employed to identify the extent of NF-κB 401 
signaling-activated mouse ovarian antral follicles conversion into atretic follicles 402 
(indicated by asterisk) by their morphologic characteristics (Fig. 6A). The results 403 
showed that PAS and Masson staining-labelled atretic follicle numbers in NF-κB 404 
signaling-activated mouse ovaries were much less than the one in wild-type mice (WT 405 
= 14.69 ± 1.558, N=13; NF-κB1C59S = 8.917 ± 0.9883, N=12; Fig. 6B). Follicular 406 
atresia is closely correlated with granulosa cell apoptosis (Lin & Rui, 2010). 407 
Therefore, immunofluorescent staining against FasL, Fas and C-capses3 was 408 
performed on the mouse transverse sections to evaluate the effects of NF-κB signaling 409 
on cell apoptosis of the ovarian secondary and antral follicles (Fig. 6C). The results 410 
demonstrated that FasL, Fas and C-capses3 were mainly expressed in granulosa cells 411 
(Fig. 6C), and activation of NF-κB signaling reduced the positive ratios of FsaL 412 
(Secondary: WT = 24.00 ±1.862%, N=6; NF-κB1C59S = 16.17 ± 1.216%, N=6; Antral: 413 
WT = 25.35 ± 2.040%, N=6; NF-κB1C59S = 11.42 ± 1.578%, N=6; Fig. 6D) and 414 
C-caspases3 (Secondary: WT = 38.17 ±3.664%, N=6; NF-κB1C59S = 27.00 ± 1.862%, 415 
N=6; Antral: WT = 41.67 ± 2.813%, N=6; NF-κB1C59S = 25.20 ± 3.175%, N=6; Fig. 416 
6F) expression on the granulosa cells of secondary and antral follicles. Meanwhile, 417 
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Fas expressionon the granulosa cells of antral follicles was also lower in comparison 418 
to wild-type mice (WT = 16.95 ± 0.8597%, N=6; NF-κB1C59S = 9.85 ± 1.013%, N=6; 419 
Fig. 6E). Using quantitative PCR, we determined the mRNA expressions of a number 420 
of cell apoptosis-related factors. Expression of Faswas unchanged, Bcl-2 increased 421 
and expressions of FasL, Bax, PUMA, and P53 were reduced in NF-κB 422 
signaling-activated mouse ovaries compared to wild-type ones (Fas:WT = 1.000 ± 423 
0.1186, N=3; NF-κB1C59S = 1.003 ± 0.09953, N=3; Fasl: WT = 1.000 ± 0.04608, N=3; 424 
NF-κB1C59S = 0.4009 ± 0.04047, N=3; Bcl-2: WT = 1.000 ± 0.03217, N=3; 425 
NF-κB1C59S= 8.703 ± 0.5728, N=3; Bax:WT = 1.000 ± 0.04390, N=3; NF-κB1C59S = 426 
0.5819 ± 0.08119, N=3; PUMA: WT = 1.000 ± 0.09993, N=3; NF-κB1C59S = 0.4077 ± 427 
0.03884, N=3; P53: WT = 1.000 ± 0.07817, N=3; NF-κB1C59S = 0.5967 ± 0.09822, 428 
N=3; Fig. 6G). Similarly, western blot data showed the expressions of Fas and 429 
C-capases3 at protein level were also reduced in NF-κB signaling-activated mouse 430 
ovaries compared to wild-type (Fig. 6H; Fas: WT = 2.102 ± 0.1842, N=3; NF-κB1C59S 431 
= 0.8573 ± 0.04725, N=3; c-caspase3: WT = 0.3753 ± 0.04245, N=3; NF-κB1C59S 432 
=0.1270 ± 0.02857, N=3; Fig. 6H1). All the data suggest that elevated NF-κB 433 
signaling suppress granulosa cell apoptosis, which in turn hinder the process of 434 
follicular atresia.  435 
 436 
LPS-induced NF-κB signaling activation promoted cell proliferation and 437 
differentiation-related gene expressions in granulosa cells in vitro. 438 
To further investigate the role of NF-κB signaling in granulosa cells, we enhanced 439 
NF-κB signaling in COV434 cells, a human ovarian granulosa tumor cell line, and 440 
exposed them to lipopolysaccharides (LPS). Cell Counting Kit-8 (CCK-8), a 441 
colorimetric assay kit, was employed to assess COV434 cell proliferation and 442 
cytotoxicity to various concentrations of LPS (Fig. 7A). The results showed that the 443 
exposure to 1μg and 5μg/ml LPS for 48 hours could increase cell viability, but 444 
10μg/ml LPS for 48 hours suppressed cell viability (24h: Control =100.0 ± 1.657%, 445 
N=6; LPS 1μg/ml = 101.3 ± 6.392%, N=6;LPS 5μg/ml = 93.45 ± 2.489%, N=6; LPS 446 
10μg/ml = 103.4 ±1.740%, N=6; 48h: Control = 100.0 ± 5.217%, N=6; LPS 1μg/ml = 447 
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138.2 ± 9.573%, N=6; LPS 5μg/ml = 142.4 ±14.27%, N=6; LPS 10μg/ml = 108.5 ± 448 
3.757%, N=6; Fig. 7A). P65 immunofluorescent staining showed that 1μg/ml LPS 449 
exposure increased p65 nuclear translocation in COV434 cells (Fig. 7B; Control = 450 
11.18 ± 2.475%, N=5; LPS = 27.12 ± 2.057%, N=5; Fig. 7B1).Western blot data 451 
showed that 1μg/ml LPS exposure increased p65 expression and reduced IκBα 452 
expression (Fig. 7C; p65: Control = 0.2827 ± 0.03636, N=3; LPS = 0.4960 ± 0.03523, 453 
N=3; IκBα: Control = 1.098 ± 0.07959, N=3; LPS = 0.8256 ± 0.02862, N=3; Fig. 454 
7C1). Those data indicates that NF-κB signaling was indeed activated by the exposure 455 
of 1μg/ml LPS in COV434 cells in vitro. To assess the correlation between activation 456 
of NF-κB signaling and FSH-regulated granulosa cell activities, we determined the 457 
expressions of FSH receptor, phosphate-AKT and PCNA using western blotting in 458 
presence of 1μg/ml LPS. The results showed that 1μg/ml LPS exposure increased the 459 
expressions of FSH receptor, phosphate-AKT and PCNA at the protein level in 460 
COV434 cells (Fig. 7D; FSHR: Control = 0.4303 ±0.02537, N=3; LPS = 0.5080 ± 461 
0.01172, N=3; P-AKT: Control = 0.2313 ±0.01041, N=3; LPS = 0.2935 ± 0.01843, 462 
N=3; PCNA: Control = 0.4703 ± 0.02063, N=3; LPS = 0.5497 ± 0.01889, N=3; Fig. 463 
7D1). Meanwhile, quantitative PCR was employed to determine the expressions of 464 
NF-κB signaling-related genes in COV434 cells exposed to LPS. The results showed 465 
that 1μg/ml LPS exposure regressed IκBα expression; did not change TRAF6 466 
expression; increased TNFɑ, IL-6, IL-8 expressions (IκBα: Control = 1.000 ± 0.09502, 467 
N=3; LPS = 0.4203 ± 0.08182, N=3; TRAF6: Control = 1.000 ± 0.04847, N=3; LPS 468 
=0.8216 ±0.1663, N=3; TNFɑ: Control = 1.000 ± 0.1976, N=3; LPS = 3.283 ± 0.4710, 469 
N=3; IL-6: Control = 1.000 ± 0.09318, N=3; LPS = 3.500 ± 0.6464, N=3; IL-8: 470 
Control = 1.000 ± 0.04035, N=3; LPS = 5.028 ± 0.6371, N=3; Fig. 7E).  471 
 To further verify these observations, FSHR expression and COV434 cell 472 
proliferation was determined when NF-κB signaling was blocked through application 473 
of BAY 11-7082, a NF-κB inhibitor (Fig. 8). BAY 11-7082 is a specific inhibitor 474 
inducing IκBα phosphorylation, which can suppress the NF-κB signaling 475 
pathway(Kamthong & Wu, 2001).The BAY 11-7082 concentration used in the range 476 
of 2.5-10 µM did not display the signs of cytotoxicity in previous study (Xia et al., 477 
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2018). So 5μM BAY 11-7082 treatment for 12 hours was chosen since cell 478 
proliferation and cytotoxicity assays with CCK-8 indicated no effect on COV434 cell 479 
viability (12h: Control = 100.0 ± 3.650%, N=6; BAY 11-7082 5μM = 91.52 ± 5.050%, 480 
N=6; BAY 11-7082 10μM = 81.73 ±6.097%, N=6; 24h: Control = 100.0 ± 1.891%, 481 
N=6; BAY 11-7082 5μM = 73.77±2.696%, N=6; BAY 11-7082 10μM = 64.49 ± 482 
4.205%, N=6; 48h: Control = 100.0 ±3.160%, N=6; BAY 11-7082 5μM = 77.49 ± 483 
1.576%, N=6; BAY 11-7082 10μM = 51.85 ± 2.810%, N=6; Fig. 8A). p65 and FSHR 484 
immunofluorescent staining confirmed 1μg/ml LPS exposure promoted p65 transfer 485 
into the nucleus and promoted FSHR expression (Fig. 8B-B1). However, the 486 
reduction of p65 expression indicated the successful blockage of NF-κB signaling 487 
with BAY 11-7082and the subsequent NF-κB signaling blockage lead to the 488 
regression of FSHR expression in COV434 cells (Fig. 8B; Control =41.93 ±4.294%, 489 
N=4; LPS = 55.28 ± 3.161%, N=4; BAY 11-7082 = 29.88 ± 2.207%, N=4; Fig. 8B1). 490 
Meanwhile, 1μg/ml LPS exposure promoted COV434 cell proliferation and 491 
suppressed COV434 cell apoptosis, but blockage of NF-κB signaling with BAY 492 
11-7082 suppressed COV434 cell proliferation (Fig. 8C; Control = 43.05 ± 2.235%, 493 
N=4; LPS = 52.23 ± 2.925%, N=4; BAY 11-7082 = 27.03± 2.235%, N=4; Fig. 8C1) 494 
and promoted COV434 cell apoptosis (Fig. 8D; Control = 5.233 ± 0.2333%, N=3; 495 
LPS = 2.603 ± 0.5323%, N=3; BAY 11-7082 = 74.07 ± 1.848%, N=3; Fig. 8D1). All 496 
of the data suggest that LPS-activated NF-κB signaling could be directly involved in 497 
FSH-mediating granulosa cell viability and proliferation. 498 
 499 
 500 
Discussion 501 
NF-κB signaling is involved in numerous cellular events under normal 502 
physiological states and disorders. However, the role of of NF-κB signaling in 503 
follicular development is not well understood. To address this issue, the expression 504 
patterns of IκB, p65 and p50, the marker molecules of NF-κB signaling, were 505 
determined in wild-type mouse developing ovarian follicles (Fig. 1). Degradation of 506 
IκB proteins induced by any signaling could activate NF-κB(Solt & May, 2008). As 507 
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one of NF-κB transcription factor family’s five components, p65 forms heterodimers 508 
and translocates from the cytoplasm to the nucleus in the NF-κB signaling pathway 509 
presented in most cell types (Basseres & Baldwin, 2006). IκB expression increased 510 
from primordial to secondary follicles, but it decreased when ovarian follicles 511 
developed into antral follicles, while p65 and p50 expression constantly went up at all 512 
stages through to antral follicles (Fig. 1A-L), implying that the activation of the 513 
NF-κB signaling pathway in granulosa cells probably promotes the conversion of 514 
secondary follicles into antral follicles (Fig. 1M). To investigate this assumption, 515 
active NF-κB signaling transgenic mice were generated by using knockin approach. 516 
Cysteine at the number 59 amino acid of the sixth exon (NF-κB1, p50 gene) was 517 
converted into serine (Fig. 2A), as previously reported (Toledano, Ghosh, Trinh, & 518 
Leonard, 1993). In the activated NF-κB signaling mouse ovaries, lower expression of 519 
IκB in granulosa cells (Fig. 2E), higher expression of p50 in granulosa cells 520 
(Supplementary Fig. 3) and an increase of p65 nuclear translocation in granulosa cells 521 
was observed (Fig. 2F). This proves NF-κB signaling was activated in granulosa cells 522 
of secondary follicles and antral follicles. This physiological activation by just 523 
increasing p50 DNA-binding activity was more meaningful than the other way, such 524 
as continuously activating NF-κB by exogenous signals.  525 
Next, the mouse ovarian follicular development was determined following the 526 
activation of NF-κB signaling by carefully counting the numbers of the variety of 527 
developing follicles on HE stained transverse sections (Fig. 3A). This indicated that 528 
there were no significant alterations of the numbers of primary, secondary follicles 529 
and corpus luteum except for antral follicles between wild-type and active NF-κB 530 
mice (Fig. 3B). CYP19a1, FSH and FSHR are responsible for estradiol production in 531 
ovarian granulosa cells through the cAMP-PKA pathway (Kim, Pyun, Cha, Ko, & 532 
Kwack, 2011). Therefore, the observed increase of CYP11a1 and 533 
CYP19a1expressions in active NF-κB ovaries compared to wild-type (Fig. 3C-E) also 534 
suggested the promotion of antral follicular development by activation of NF-κB 535 
signaling. FSH signals activate the heptahelical G protein-coupled FSHR in granulosa 536 
cells to promote follicular maturation(Park et al., 2005). Folliculogenesis involves the 537 
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activation of a small number of primordial follicles which then develop and pass 538 
through the primary, secondary and antral stages. These follicle stages involves very 539 
precise cellular and molecular interactions (Roche, 1996; Scaramuzzi et al.). 540 
Granulosa cells are normally indispensable for inducing and supporting the 541 
development of the ovarian follicles (Li et al., 1998; Porter, Vickers, Cowan, Huber, 542 
& Quirk, 2000). It is generally recognized that the interaction of autocrine and 543 
paracrine effectors, as well as FSH and LH ultimately determines the developmental 544 
fate of the developing follicles (Roche, 1996; Scaramuzzi et al., 2011). In this study, 545 
higher FSHR and LHCGR expressions were found in active NF-κB ovaries compared 546 
to wild-type (Fig. 4). This quantitative alteration of antral follicular numbers and the 547 
enhanced corresponding steroid hormone receptor confirm that NF-κB signaling is 548 
somehow involved in regulating the transition from ovarian secondary to antral 549 
follicles.  550 
Using Ki67 and PCNA immunofluorescent staining, it was demonstrated that the 551 
activation of NF-κB signaling definitely enhanced the granulosa cell proliferation in 552 
secondary and antral follicles (Fig. 5A-A2). Western blotting result also showed that 553 
higher PCNA expression in active NF-κB ovaries compared to wild-type (Fig. 5B-B1). 554 
These data indicated that the granulosa cells’ ability to respond to FSH-stimulated cell 555 
proliferation was dramatically promoted under the activation of NF-κB signaling. 556 
There is no doubt that the vigorous granulosa cell proliferation in turn also accelerates 557 
the maturation of ovarian follicles (Maruo et al., 1999). In addition, folliculogenesis at 558 
later stages of development is largely mediated by oocyte-granulosa-theca cell 559 
interactions. Granulosa cells and cumulus cells, the two anatomically and functionally 560 
obvious layers, are also responsible for nurturing oocyte development and subsequent 561 
acquisition. That is to say, oocyte and granulosa cell/cumulus cell communication is 562 
bidirectional, which is illustrated by potent growth factors secreted by oocytes directly 563 
influencing the differentiation and function of granulosa cells. Gdf9 and Bmp15 are 564 
the most important two oocyte-secreted factors (OSFs) enabling oocytes apparent 565 
ability to regulate their neighboring somatic cells and guiding them to implement 566 
functions (Gilchrist, Lane, & Thompson, 2008). Furthermore, during follicular 567 
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transitional stage, granulosa factors promote the recruitment of theca cells from 568 
stromal cells, while oocyte-derived Gdf9 maintains follicular development from 569 
pre-antral to antral stage by regressing granulosa cell apoptosis (Orisaka, Tajima, 570 
Tsang, & Kotsuji, 2009; Thomas & Vanderhyden, 2006). In this study, Bmp15 and 571 
Gdf9 were up-regulated in active NF-κB signaling mice (Fig. 5C), implying activation 572 
of NF-κB signaling enhances the FSH-induced response of granulosa cells on 573 
differentiation and proliferation. Meanwhile, PAS and Masson staining clearly 574 
showed that activation NF-κB signaling suppressed the process of follicular atresia 575 
(Fig. 6A-B), which was further confirmed by the down-regulation of Fas/Fasl and 576 
C-capsese3 in granulosa cells of secondary and antral follicles in active NF-κB mice 577 
(Fig. 6C-H). This finding also verifies the role of NF-κB signaling on follicular 578 
maturation.       579 
NF-κB signaling is the initial cellular responder to harmful stimuli, which could 580 
include bacterial lipopolysaccharides (LPS), reactive oxygen species (ROS), tumor 581 
necrosis factor alpha (TNFα), interleukin 1-beta (IL-1β) and ionizing radiation 582 
(Chandel, Trzyna, McClintock, & Schumacker, 2000). This allows us to validate the 583 
observation mentioned above in active NF-κB mice using COV434, a granulosa cell 584 
line, exposed to LPS in vitro (Fig. 7). In this study, 1μg/mland 5μg/ml LPS exposure 585 
stimulated COV434 cell viability, but 10μg/ml LPS exposure suppressed it. This 586 
indicatesthat only certain levels of NF-κB signaling changes promote granulosa cell 587 
viability. Moreover, 1μg/ml LPS exposure promoted p65 nuclear translocation, IκBa 588 
down-regulation, FSH receptor, TNFɑ, IL-6 and IL-8 up-regulation (Fig. 7). In order 589 
to confirm the level of NF-κB signaling that could stimulate granulosa cell viability, 590 
NF-κB signaling was blocked by the addition of a NF-κB inhibitor, BAY11-7082, 591 
which was added into the culture medium of COV434 cells. The BAY11-7082 592 
suppressed p65 nuclear translocation and inhibited cell survival, but this may also be 593 
through the regulation of FSHR expression (Fig. 8). All the data suggest that NF-κB 594 
signaling is closely associated with granulosa cell proliferation, apoptosis and 595 
differentiation, which are regulated by FSHR and its downstream products at the late 596 
stage of follicular development.   597 
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In this study, the role of NF-κB signaling on ovarian follicular development is for 598 
the first time revealed as illustrated in Fig. 9. Briefly, NF-κB signaling in granulosa 599 
cells of developing follicles is particularlyactivated during the transition from 600 
secondary to antral follicles. Activated NF-κB signaling suppresses apoptosis and 601 
promotes proliferation and differentiation of granulosa cells, which also mostly occurs 602 
during the transition from secondary to antral follicles. This study provides, to our 603 
knowledge, the first experimental evidence that NF-κB signaling is involved in the 604 
control of follicular development through FSHR and its corresponding target 605 
molecules. Nevertheless, more experiments are needed to be precisely conducted 606 
before the full role of the physiological functions of NF-κB signaling in ovarian 607 
follicular development can be completely addressed. 608 
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 760 
Figure legends 761 
Fig. 1. IκBα, p65 and p50 expression patterns in developing mouse ovarian follicles 762 
A-D: Representative IκBαimmunofluorescent micrographs of primordial follicle 763 
(A), primary follicle (B), secondary follicle (C) and antral follicle (D) on the ovarian 764 
transverse sections of 25-week C57 mice. A1-D1: Merged images of DAPI staining 765 
and A-D respectively. E-H: Representative p65immunofluorescent micrographs of 766 
primordial follicle (E), primary follicle (F), secondary follicle (G) and antral follicle 767 
(H) on the ovarian transverse sections of 25-week C57 mice. E1-H1: Merged images 768 
of DAPI staining and E-H respectively. I-L: Representative 769 
p50immunohistochemistry micrographs of primordial follicle (I), primary follicle (J), 770 
secondary follicle (K) and antral follicle (L) on the ovarian transverse sections of 771 
25-week C57 mice. I1-L1: Negative of immunohistochemistry. M: Sketches 772 
illustrating the expression patterns of IκBα, p65 and p50 in mouse developing ovarian 773 
follicles. Abbreviation: Pdf, primordial follicle; PF, primary follicle; SF, secondary 774 
follicle; AF, antral follicle; TC, theca cells; GC, granulosa cells; ZP, zona pellucida. 775 
Scale bars = 30μm in A-L1. 776 
 777 
Fig. 2. Establishing active NF-κB transgenic mice   778 
A: Transgene schematic through altering NF-Κb1(p50)sequence of bases on 6th 779 
exon.B: Representative ovary appearance of 25-week-old wild-type and active NF-κB 780 
transgenic mice. B1-B2: The scatterplot and bar chart comparing the ovarian weights 781 
(B1) and surface area (B2) between wild-type and active NF-κB group. C-D: Bar 782 
charts showing the quantitative PCR data about the mRNA expressions (normalized to 783 
GAPDH) of IκBα (C) and p65 (D) between wild-type and active NF-κB mouse 784 
ovaries. E: Representative IκBαimmunofluorescent micrographs of secondary and 785 
antral follicle (left panels: IκBα staining only; middle panels: IκBα + DAPI staining; 786 
right panels: high magnification of the dotted areas in the middle panels) on the 787 
ovarian transverse sections of 25-week wild-type and active NF-κB mice.E1-E2: Bar 788 
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charts showing the ratio comparisons of IκBα positive cell numbers in total DAPI 789 
positive cells of secondary follicles (E1) or antral follicles (E2) between wild-type and 790 
active NF-κB mouse ovaries. F: Representative p65immunofluorescent micrographs 791 
of secondary (upper panel: wild-type; lower panel: active NF-κB) on the ovarian 792 
transverse sections of 25-week wild-type and active NF-κB mice.F1: The bar chart 793 
showing the percentages of p65 expressing in ovarian granulosa cell nucleuses 794 
between wild-type and active NF-κB mouse ovaries. G-G1: Western blot showing the 795 
IκBα expression at protein level in wild-type and active NF-κB mouse ovaries (G). 796 
Bar chart (G1) showing the relative comparison of IκBα expression(normalized to 797 
β-actin)revealed by western blot. Abbreviation: SF, secondary follicle; AF, antral 798 
follicle; GC, granulosa cells; ZP, zona pellucida. *p<0.05 , **p<0.01 and ***p<0.001 799 
indicate significant difference between control and experimental groups. Scale bars = 800 
400μm in B; 20μm in E-F. 801 
 802 
Fig. 3. Alteration on the ovarian follicles in the active NF-κB mouse ovaries  803 
A: Representative HE stained ovarian transverse sections from 25-week-old 804 
wild-type (left panel) and active NF-κB (right panel) mice. B: Bar chart showing the 805 
comparisons of various ovarian follicle numbers between wild-type and active NF-κB 806 
mouse ovaries. C-E: Quantitative PCR data showing the relative mRNA expressions 807 
(normalized to GAPDH) of CYP11a1 (C), CYP17a1 (D) and CYP19a1 (E) between 808 
wild-type and active NF-κB mouse ovaries. F: Sketches illustrating the potential 809 
target point of NF-κB pathway during the development of ovarian follicles. 810 
Abbreviation: SF, secondary follicle; AF, antral follicle. *p<0.05 and ***p<0.001 811 
indicate significant difference between control and experimental groups. Scale bars = 812 
200μm in A. 813 
 814 
Fig. 4. FSHR and LHCGR expression in ovarian follicles  815 
A-B: Representative micrographs of antral follicles immunofluorescently stained 816 
for FSHR (Follicle Stimulating Hormone Receptor) (A) and LHCGR (Luteinizing 817 
Hormone/Choriogonadotropin Receptor) (B) in the wild-type and active NF-κB 818 
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mouse ovaries. The low panels were the higher magnification of dotted areas in each 819 
immunofluorescence. C: Quantitative PCR data showing the relative mRNA 820 
expressions (normalized to GAPDH) of FSHR and LHCGR in wild-type and active 821 
NF-κB mouse ovaries. D-D1: Western blot showing the FSHR expression at protein 822 
level in wild-type and active NF-κB mouse ovaries (D). The bar chart (D1) showing 823 
the relative comparison of FSHR expression(normalized to β-actin)revealed by 824 
western blot. Abbreviation: GC, granulosa cells. *p<0.05 and ***p<0.001 indicate 825 
significant difference between control and experimental groups. Scale bars = 20μm in 826 
A-B. 827 
 828 
Fig. 5. Granulosa cell proliferation using immunofluorescent or quantitative PCR 829 
and western blot  830 
A: Representative micrographs of secondary and antral ovarian follicles 831 
immunofluorescently stained for Ki67 (the upper two panels) and PCNA (the lower 832 
two panels) to demonstrate the extent of granulosa cell proliferation in the wild-type 833 
and active NF-κB mouse ovarian follicles. The low panels were the higher 834 
magnification of dotted areas in each immunofluorescence. A1-A2: Bar charts 835 
comparing the percentages of Ki67+ (A1) and PCNA+ (A2) granulosa cells in 836 
secondary and antral follicles of 25-week-old wild-type and active NF-κB mouse 837 
ovarian follicles. B-B1: Western blot showing the PCNA expression at protein level in 838 
wild-type and active NF-κB mouse ovaries (B). The bar chart (B1) showing the 839 
relative comparison of PCNA expression (normalized to β-actin) revealed by western 840 
blot. C: Quantitative PCR data showing the relative mRNA expressions (normalized 841 
to GAPDH) of Bmp15 and Gdf9 in wild-type and active NF-κB mouse ovaries. 842 
Abbreviation: SF, secondary follicle; AF, antral follicle; GC, granulosa cells. *p<0.05 , 843 
**p<0.01 and ***p<0.001 indicate significant difference between control and 844 
experimental groups. Scale bars = 20μm in A. 845 
 846 
Fig. 6. Granulosa cell apoptosis using immunofluorescent or quantitative PCR and 847 
western blot  848 
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A-B: Representative micrographs of 25-week-old wild-type (the left panel) and 849 
active NF-κB (the right panel) mouse ovarian transverse sections histochemically 850 
stained with PAS (the upper panel) or Masson (the lower panel) (A). Bar chart 851 
comparing the atretic follicle numbers between wild-type and active NF-κB mouse 852 
ovaries (B). C: Representative micrographs of secondary and antral follicles 853 
immunofluorescently stained for FasL (the first and second panels, in which the 854 
second panel is merge of FasL and DAPI staining), Fas (the third and forth panels, in 855 
which the forth panel is merge of Fas and DAPI staining), and C-caspase3 (the fifth 856 
panel - the merge of C-caspase3 and DAPI staining) in the wild-type and active 857 
NF-κB mouse ovarian follicles. D-F: Bar charts comparing the percentages of FasL+ 858 
(D), Fas+ (E), and C-caspase3+ (F) granulosa cell ratios in every secondary and antral 859 
follicle between wild-type and active NF-κB mouse ovaries. G: Quantitative PCR 860 
data showing the relative mRNA expressions (normalized to GAPDH) of 861 
apoptosis-related genes including Fas, FasL, Bcl-2, Bax, PUMA and P53 in wild-type 862 
and active NF-κB mouse ovaries. H-H1: Western blot showing the Fas and 863 
C-caspase3 expression at protein level in wild-type and active NF-κB mouse ovaries 864 
(H). The bar chart (H1) showing the relative comparison of Fas and C-caspase3 865 
expression (normalized to β-actin) revealed by western blot. Abbreviation: SF, 866 
secondary follicle; AF, antral follicle; Atf, atretic follicle; ZP, zona pellucida; GC, 867 
granulosa cells. *p<0.05 , **p<0.01 and ***p<0.001 indicate significant difference 868 
between control and experimental groups. Scale bars = 50μm in A and C. 869 
 870 
Fig. 7. Cell viability and the expressions of NF-κB pathway crucial molecules in 871 
COV434 cells in presence of LPS  872 
A: Cell Counting Kit-8 (CCK-8) was employed to determine cell viabilities of 873 
COV434 cells exposed to the various concentrations of LPS. B-B1: Representative 874 
micrographs of COV434 cells immunofluorescently stained p65 and counterstained 875 
DAPI in control (the upper panel) and LPS-treated (the lower panel) group. Bar chart 876 
comparing the p65 nuclear translocation ratios (percentage) in all cell between control 877 
and LPS-treated group (B1). C-C1: Western blot showing the p65 and IκBα 878 
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expression at protein level in COV434 cells from control and LPS-treated group (C). 879 
The bar chart (C1) showing the relative comparison of p65 and IκBα expression 880 
revealed by western blot. D-D1: Western blot showing the FSHR, P-AKT and PCNA 881 
expression at protein level in COV434 cells from control and LPS-treated group (D). 882 
The bar chart (D1) showing the relative comparison of FSHR, P-AKT and PCNA 883 
expression (normalized to β-actin) revealed by western blot. E: Quantitative PCR data 884 
showing the relative mRNA expressions (normalized to PPIA) of IκBα, TRAF6, 885 
TNFɑ, IL-6 and IL-8 in COV434 cells from control and LPS-treated group. *p<0.05 886 
and **p<0.01 indicate significant difference between control and experimental groups. 887 
Scale bars = 20μm in B. 888 
 889 
Fig 8. Cell viability, proliferation and apoptosis of COV434 cells following blockage 890 
of NF-κB pathway. 891 
 A: Cell Counting Kit-8 (CCK-8) was employed to determine cell viabilities of 892 
COV434 cells exposed to the various concentrations of Bay11-7082 (NF-κB 893 
inhibitor). B-B1: Representative micrographs of COV434 cells immunofluorescently 894 
stained p65 (green), FSHR (red) and counterstained DAPI (blue) in control (the first 895 
panel), LPS-treated (the secondary panel) and Bay11-7082-treated (the third panel) 896 
group (B). Bar chart (B1) comparing the percentage of FSHR+ granulosa cells in total 897 
cells among control, LPS-treated and Bay11-7082-treated group. C-C1: 898 
Representative micrographs of COV434 cells immunofluorescently stained Ki67 (red) 899 
and counterstained DAPI (blue) in control (the first panel), LPS-treated (the 900 
secondary panel) and Bay11-7082-treated (the third panel) group (C). Bar chart (C1) 901 
comparing the percentage of Ki67+ granulosa cells in total cells among control, 902 
LPS-treated and Bay11-7082-treated group. D-D1: Representative micrographs of 903 
COV434 cells (bright-field), immunofluorescently stained PI (red) and counterstained 904 
DAPI (blue) in control (the first panel), LPS-treated (the secondary panel) and 905 
Bay11-7082-treated (the third panel) group (D). Bar chart (D1) comparing the 906 
percentage of PI+ granulosa cells in total cells among control, LPS-treated and 907 
Bay11-7082-treated group. *p<0.05 , **p<0.01 and ***p<0.001 indicate significant 908 
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difference between control and experimental groups. Scale bars = 20μm in B; 30μm in 909 
C-D. 910 
 911 
Fig 9. Involvement ofNF-κB pathway is in the regulation of mouse folliculogenesis. 912 
 913 
